The shortage of medicines has increased worldwide in recent years. Switzerland is no exception. A few years ago, there was a shortage of around 200 medicines in Switzerland, but today the figure has risen to over 1,000. What are the reasons for this development? And what does the actual situation really look like? Should we fear that life-saving cancer medicines will soon no longer be available?

We want to explore these questions with leading experts and at the same time shed light on the fact that there is much more at stake when it comes to the security of supply of medicines. Because, future access to innovative therapies in Switzerland is also at risk, even if the out-of-stock reports of generics are more prominent in the media.